Zeltiq Aesthetics, Inc. v. POBRA Enterprises, LLC et al

Filing 73

PERMANENT INJUNCTION. Signed by Judge Sheri Polster Chappell on 7/21/2017. (LMF)

UNITED STATES DISTRICT COURT
MIDDLE DISTRICT OF FLORIDA
FORT MYERS DIVISION
ZELTIQ AESTHETICS, INC.,
Plaintiff/Counterclaim-Defendant,
v.

Case No: 2:16-cv-792-FtM-38MRM

POBRA ENTERPRISES, LLC,
NAPLES POBRA LLC, JOHN
BRANNELLY, MICHAEL A. POKA,
and ANDREA BASILE,
Defendants, CounterclaimPlaintiffs.
/
PERMANENT INJUNCTION
This matter is before the Court on the Parties’ Stipulated Entry of Permanent
Injunction, signed by all parties. (Doc. 71). Being sufficiently advised, the following
Permanent Injunction is hereby issued.
Accordingly, it is now
ORDERED:
Defendants POBRA Enterprises, LLC d/b/a Swan Age Reversal Centers, Swan
Cosmetic LLC f/k/a Naples POBRA, LLC d/b/a Swan Centers, John Brannelly, and
Michael A. Poka (collectively, “Swan Defendants”), their successors, assigns,
representatives, agents, principals, partners, officers, managers, directors, employees,
members, shareholders, or anyone acting in concert with or under their direction and
control are permanently restrained and enjoined from:
(a) Using the marks Zeltiq®, CoolSculpting®, Cryolipolysis®, Zeltiq’s Snowflake
Logo, and/or any other Zeltiq mark or any confusingly similar mark or colorable imitation

thereof in connection with the promotion, advertisement, display, sale, or distribution of
any goods or services offered by the Swan Defendants;
(b) Performing any act, making any statement, or distributing any materials that
are likely to lead members of the public to believe that any device(s) owned or services
performed, distributed, leased, or sold by the Swan Defendants are associated or
connected with Zeltiq, or are sold, licensed, sponsored, approved or authorized by Zeltiq,
or provide services that are the clinical equivalent of any goods or services offered by
Zeltiq;
(c) Reproducing, displaying, distributing, or creating derivative works from any text,
graphics, photographs, videos, or other materials owned by and/or emanating from Zeltiq
or its Authorized Providers concerning Cryolipolysis and the results therefrom;
(d) Offering or performing cooling-based body contouring services with any device
unless such device is cleared by the United States Food and Drug Administration and the
Swan Defendants can show that it does not infringe on any patent owned or licensed by
Zeltiq; and
(e) Otherwise taking any action likely to cause public confusion, mistake, or
deception as to the connection, affiliation, sponsorship, approval, or other association of
the Swan Defendants’ goods or services with Zeltiq or its goods or services.
DONE and ORDERED in Fort Myers, Florida this 20th day of July, 2017.

Copies: All Parties of Record

2